136 related articles for article (PubMed ID: 16032587)
1. Systemic meloxicam reduces tactile allodynia development after L5 single spinal nerve injury in rats.
Takahashi M; Kawaguchi M; Shimada K; Nakashima T; Furuya H
Reg Anesth Pain Med; 2005; 30(4):351-5. PubMed ID: 16032587
[TBL] [Abstract][Full Text] [Related]
2. Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation.
Takeda K; Sawamura S; Tamai H; Sekiyama H; Hanaoka K
Anesthesiology; 2005 Oct; 103(4):837-44. PubMed ID: 16192777
[TBL] [Abstract][Full Text] [Related]
3. Spinal nerve injury activates prostaglandin synthesis in the spinal cord that contributes to early maintenance of tactile allodynia.
Hefferan MP; Carter P; Haley M; Loomis CW
Pain; 2003 Jan; 101(1-2):139-47. PubMed ID: 12507708
[TBL] [Abstract][Full Text] [Related]
4. Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats.
Zhao Z; Chen SR; Eisenach JC; Busija DW; Pan HL
Neuroscience; 2000; 97(4):743-8. PubMed ID: 10842019
[TBL] [Abstract][Full Text] [Related]
5. Topical high molecular weight hyaluronan reduces radicular pain post laminectomy in a rat model.
Massie JB; Schimizzi AL; Huang B; Kim CW; Garfin SR; Akeson WH
Spine J; 2005; 5(5):494-502. PubMed ID: 16153575
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury.
Ma W; Eisenach JC
Neuroscience; 2003; 121(3):691-704. PubMed ID: 14568029
[TBL] [Abstract][Full Text] [Related]
7. [Therapy with preferential and specific COX-2 inhibitors].
Stichtenoth DO; Frölich JC
Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028
[No Abstract] [Full Text] [Related]
8. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study.
Villegas I; Martín MJ; La Casa C; Motilva V; De La Lastra CA
Free Radic Res; 2002 Jul; 36(7):769-77. PubMed ID: 12180128
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
10. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y
Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076
[TBL] [Abstract][Full Text] [Related]
11. Nerve injury-induced tactile allodynia is mediated via ascending spinal dorsal column projections.
Sun H; Ren K; Zhong CM; Ossipov MH; Malan TP; Lai J; Porreca F
Pain; 2001 Feb; 90(1-2):105-11. PubMed ID: 11166976
[TBL] [Abstract][Full Text] [Related]
12. Meloxicam selectively depresses the afterdischarge of rat spinal dorsal horn neurones in response to noxious stimulation.
Pitcher GM; Henry JL
Neurosci Lett; 2001 Jun; 305(1):45-8. PubMed ID: 11356304
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of antiallodynic effects of the cyclooxygenase-2 inhibitor meloxicam on established diabetic neuropathic pain in mice.
Kimura S; Kontani H
J Pharmacol Sci; 2009 Jun; 110(2):213-7. PubMed ID: 19498273
[TBL] [Abstract][Full Text] [Related]
14. Aspirin, but not the more selective cyclooxygenase (COX)-2 inhibitors meloxicam and SC 58125, aggravates postischaemic cardiac dysfunction, independent of COX function.
Heindl B; Becker BF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):233-40. PubMed ID: 11218076
[TBL] [Abstract][Full Text] [Related]
15. Ameliorative effect of combined administration of inducible nitric oxide synthase inhibitor with cyclooxygenase-2 inhibitors in neuropathic pain in rats.
Dudhgaonkar SP; Tandan SK; Kumar D; Naik AK; Raviprakash V
Eur J Pain; 2007 Jul; 11(5):528-34. PubMed ID: 16920373
[TBL] [Abstract][Full Text] [Related]
16. Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain.
Malan TP; Mata HP; Porreca F
Anesthesiology; 2002 May; 96(5):1161-7. PubMed ID: 11981157
[TBL] [Abstract][Full Text] [Related]
17. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.
Villegas I; Alarcón de la Lastra C; La Casa C; Motilva V; Martín MJ
Eur J Pharmacol; 2001 Feb; 414(1):79-86. PubMed ID: 11230998
[TBL] [Abstract][Full Text] [Related]
18. Meloxicam, a specific COX-2 inhibitor, does not enhance the isoflurane minimum alveolar concentration reduction produced by morphine in the rat.
Santos M; Kunkar V; García-Iturralde P; Tendillo FJ
Anesth Analg; 2004 Feb; 98(2):359-363. PubMed ID: 14742370
[TBL] [Abstract][Full Text] [Related]
19. Central antinociceptive effects of meloxicam on rat spinal cord in vitro.
Lopez-Garcia JA; Laird JM
Neuroreport; 1998 Mar; 9(4):647-51. PubMed ID: 9559932
[TBL] [Abstract][Full Text] [Related]
20. [The effect of cyclooxygenase-2 inhibitor on acute lung injury].
Wang J; Mao B; Chen Z
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jun; 22(6):351-3. PubMed ID: 11775825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
